You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中国再生医学(08158.HK)拟折让约10.71%增发2.3亿股
格隆汇 10-08 20:54

格隆汇 10 月 8日丨中国再生医学(08158.HK)公告,于2020年10月8日,公司及附属公司(公司全资附属公司)分别与服务供应商订立认购及清偿协议,据此,公司有条件同意发行,而服务供应商有条件同意或促使其各自代名人以发行价每股认购股份0.20港元认购合共2.3亿股认购股份。

服务供应商将于完成时透过抵销附属公司结欠服务供应商应付账款支付认购价,而公司将向服务供应商配发及发行认购股份,作为应付账款全数及最终结付。发行价为每股认购股份0.20港元,较10月8日公司收市价每股0.224港元折让约10.71%。

认购股份将于各方面与现有股份享有同等地位,将根据一般授权配发及发行。公司将向联交所GEM上市委员会申请批准认购股份上市及买卖。

于公告日期,公司尚未根据一般授权配发及发行任何股份,而一般授权足以配发及发行所有认购股份。因此,配发及发行认购股份毋须获股东进一步批准。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account